期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Different nutrient compositions in diet and taking hypoglycemic drugs can modulate gut microbial flora
1
作者 Zi-Jun Lin Qiong-Wen Zhang +3 位作者 Xiao-Lan Yu Bo Zhou Chang-Wei Liu Lian-Ping He 《World Journal of Diabetes》 SCIE 2022年第9期799-801,共3页
The diet structure of diabetic patients is different from that of normal people.Diabetic patients also need to take hypoglycemic drugs to regulate blood sugar.Both dieting and drugs affect the gut microbiota of diabet... The diet structure of diabetic patients is different from that of normal people.Diabetic patients also need to take hypoglycemic drugs to regulate blood sugar.Both dieting and drugs affect the gut microbiota of diabetic patients.In this letter,we discuss that different dietary patterns and the use of hypoglycemic agents may have an impact on changes in gut microbiota in diabetic patients. 展开更多
关键词 Diabetic patients Gut microbiota hypoglycemic drugs
下载PDF
Vitamin D,selenium,and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis 被引量:1
2
作者 Fen Feng Bin Zhou +3 位作者 Ci-La Zhou Ping Huang Gang Wang Kuang Yao 《World Journal of Diabetes》 SCIE 2024年第2期209-219,共11页
BACKGROUND Diabetes and thyroiditis are closely related.They occur in combination and cause significant damage to the body.There is no clear treatment for type-2 diabetes mellitus(T2DM)with Hashimoto's thyroiditis... BACKGROUND Diabetes and thyroiditis are closely related.They occur in combination and cause significant damage to the body.There is no clear treatment for type-2 diabetes mellitus(T2DM)with Hashimoto's thyroiditis(HT).While single symptomatic drug treatment of the two diseases is less effective,combined drug treatment may improve efficacy.AIM To investigate the effect of a combination of vitamin D,selenium,and hypoglycemic agents in T2DM with HT.METHODS This retrospective study included 150 patients with T2DM and HT treated at The Central Hospital of Shaoyang from March 2020 to February 2023.Fifty patients were assigned to the control group,test group A,and test group B according to different treatment methods.The control group received low-iodine diet guidance and hypoglycemic drug treatment.Test group A received the control treatment plus vitamin D treatment.Test group B received the group A treatment plus selenium.Blood levels of markers of thyroid function[free T3(FT3),thyroid stimulating hormone(TSH),free T4(FT4)],autoantibodies[thyroid peroxidase antibody(TPOAB)and thyroid globulin antibody(TGAB)],blood lipid index[low-density lipoprotein cholesterol(LDL-C),total cholesterol(TC),triacylglycerol(TG)],blood glucose index[fasting blood glucose(FBG),and hemoglobin A1c(HbA1c)]were measured pre-treatment and 3 and 6 months after treatment.The relationships between serum 25-hydroxyvitamin D3[25(OH)D3]level and each of these indices were analyzed.RESULTS The levels of 25(OH)D3,FT3,FT4,and LDL-C increased in the order of the control group,test group A,and test group B(all P<0.05).The TPOAB,TGAB,TC,TG,FBG,HbA1c,and TSH levels increased in the order of test groups B,A,and the control group(all P<0.05).All the above indices were compared after 3 and 6 months of treatment.Pre-treatment,there was no divergence in serum 25(OH)D3 level,thyroid function-related indexes,autoantibodies level,blood glucose,and blood lipid index between the control group,test groups A and B(all P>0.05).The 25(OH)D3 levels in test groups A and B were negatively correlated with FT4 and TGAB(all P<0.05).CONCLUSION The combination drug treatment for T2DM with HT significantly improved thyroid function,autoantibody,and blood glucose and lipid levels. 展开更多
关键词 Type-2 diabetes mellitus Hashimoto's thyroiditis Vitamin D Selenium agent hypoglycemic drugs Curative effect
下载PDF
Pharmacotherapy of Diabetes Mellitus Type 2: A Review on Various Hypoglycemics
3
作者 Muhammad Khalid Khan Rizwan U Baig 《Journal of Clinical and Nursing Research》 2022年第5期57-67,共11页
Diabetes is a cosmopolitan medical issue ramifying a large population regardless of ethnicity.Elevated glycemic condition in a patient is explained as diabetes.It can be mainly categorized into Non-Insulin Dependent D... Diabetes is a cosmopolitan medical issue ramifying a large population regardless of ethnicity.Elevated glycemic condition in a patient is explained as diabetes.It can be mainly categorized into Non-Insulin Dependent Diabetes Mellitus(NIDDM)and Insulin Dependent Diabetes Mellitus(IDDM)or Type 1 or Type 2 respectively.Type 1 or IDDM needs insulin therapy exclusively while Type 2 can be controlled via various hypoglycemic agents.Conventional classes contain glitazones,biguanides,sulfonylurea’s and soon,while newly developed drug classes include gliptins or DPP-4 inhibitors,SGLT-2 receptor inhibitors and GLP-1 receptor agonists.The novelty in the anti-hyperglycemic agents have given promising results as compared to the conventional drugs.Insulin cannot be negated as far as its glycemic control is concerned.Furthermore,development of Insulin analogues like detemir,glargine,Lisprohave been shown to control glucose levels in the plasma more efficiently. 展开更多
关键词 Pre-prandial POSTPRANDIAL KETOACIDOSIS ADIPOGENESIS Oral hypoglycemic drugs(OHD)
下载PDF
2006~2008年我院降糖药应用分析
4
作者 史轶 《中国医院用药评价与分析》 2009年第8期585-587,共3页
目的:通过对我院降糖药数据统计、应用情况分析,以促进合理用药。方法:对我院2006~2008年降糖药的用药数量、销售金额、用药频度、限定日费用等进行统计分析。结果:3年来我院降糖药使用数量及销售金额不断增加,总销售金额每年增长近25... 目的:通过对我院降糖药数据统计、应用情况分析,以促进合理用药。方法:对我院2006~2008年降糖药的用药数量、销售金额、用药频度、限定日费用等进行统计分析。结果:3年来我院降糖药使用数量及销售金额不断增加,总销售金额每年增长近25%。降糖药物的销售金额排序阿卡波糖(拜糖平)连续3年位居榜首,DDDs排序,阿卡波糖,二甲双胍肠溶片,二甲双胍(格华止)连续3年排在前3位。注射用胰岛素中诺和灵50R笔芯,诺和灵30R笔芯,诺和灵R笔芯3年均排在前3位,甘精胰岛素用量在不断增加。结论:我院降糖药使用情况基本合理。 展开更多
关键词 降糖药 用药频度 限定日费用 用药分析
下载PDF
2003年~2005年我院降糖药应用及经济学分析 被引量:1
5
作者 康继红 郭永福 杨树声 《中国医院用药评价与分析》 2006年第5期296-298,共3页
目的:了解我院降血糖药状况与发展趋势。方法:对2003年-2005年度消耗的降血糖药用药金额、用药频度、日均费用的变化进行统计分析。结果:2003年-2004年、2004年-2005年我院降血糖药的用药频度增长42.46%和15.95%,销售金额上升47... 目的:了解我院降血糖药状况与发展趋势。方法:对2003年-2005年度消耗的降血糖药用药金额、用药频度、日均费用的变化进行统计分析。结果:2003年-2004年、2004年-2005年我院降血糖药的用药频度增长42.46%和15.95%,销售金额上升47.05%和44.30%。结论:降血糖药是一类很有发展潜力的药物,混合胰岛素和新型口服降血糖药的用量将不断增加。 展开更多
关键词 降血糖药 用药频度 用药金额 药物经济学
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部